<DOC>
	<DOCNO>NCT02488902</DOCNO>
	<brief_summary>This randomise , double-blind , placebo-controlled study compare efficacy range four weekly dos tafenoquine , weekly mefloquine , placebo chemosuppression P. falciparum malaria . Medications placebo match double-dummy technique enable blind tafenoquine versus mefloquine .</brief_summary>
	<brief_title>A Randomized , Double-blind , Placebo-controlled Evaluation Increasing Doses Weekly Tafenoquine Chemosuppression Plasmodium Falciparum</brief_title>
	<detailed_description />
	<mesh_term>Mefloquine</mesh_term>
	<mesh_term>Tafenoquine</mesh_term>
	<criteria>Willing subject good general health . Males age 18 60 ; female age 50 60 . Subjects plan stay study area end study . Subjects cardiovascular , liver , neurologic , renal function abnormality , opinion clinical investigator , would place increase risk adverse event confuse result . Subjects personal family history seizure frank psychiatric disorder . Females cease menstruation ; urine βhuman chorionic gonadotrophin ( βHCG ) test perform screen female cease menstruation exclude pregnancy cause . Females lactate . Subjects give antimalarial drug treatment within two week study drug initiation . Subjects clinically significant abnormality ( include limit abnormal hepatic renal function ) determine history , physical routine blood chemistry haematology value . Subjects know hypersensitivity study drug . Subjects unwilling remain area , report drug administration blood draw 34 month duration study . Subjects G6PD deficiency ( determine two separate qualitative test per subject administer use distinct method ; method use visual dye filter paper method ) . Subjects follow laboratory value : haemoglobin ( Hb ) &lt; 8g/dL , platelet &lt; 80,000/mm3 , white blood cell count ( WBC ) &lt; 3000/mm3 , creatinine &gt; 1.5mg/dL , alanine transaminase ( ALT ) &gt; 60IU 1+ haematuria detect urine dipstick .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>